SynthesisBMJ open2014

Safety and effectiveness of dipeptidyl peptidase-4 inhibitors versus intermediate-acting insulin or placebo for patients with type 2 diabetes failing two oral antihyperglycaemic agents: a systematic review and network meta-analysis.

Andrea C Tricco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.